Pharm Sci. 2021;27(Covid-19): S109-S121. doi: 10.34172/PS.2021.3

Research Article

Molecular Docking and Dynamics Simulations Reveal the Potential of Anti-HCV Drugs to Inhibit COVID-19 Main Protease

Ahmed Ali Al-Karmalawy 1 * ORCID, Radwan Alnajjar 2,3, Mohammed Dahab 4, Ahmed Metwaly 5, Ibrahim Eissa 4

Cited by CrossRef: 3

1- Al-Karmalawy A, Farid M, Mostafa A, Ragheb A, H. Mahmoud S, Shehata M, Shama N, GabAllah M, Mostafa-Hedeab G, Marzouk M. Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2. Molecules. 2021;26(21):6559 [Crossref]
2- Elmaaty A, Darwish K, Chrouda A, Boseila A, Tantawy M, Elhady S, Shaik A, Mustafa M, Al-karmalawy A. In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity. ACS Omega. 2022;7(1):875 [Crossref]
3- El-Demerdash A, Al-Karmalawy A, Abdel-Aziz T, Elhady S, Darwish K, Hassan A. Investigating the structure–activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors. RSC Adv. 2021;11(50):31339 [Crossref]
4- Al-Karmalawy A, Soltane R, Abo Elmaaty A, Tantawy M, Antar S, Yahya G, Chrouda A, Pashameah R, Mustafa M, Abu Mraheil M, Mostafa A. Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview. Vaccines. 2021;9(11):1317 [Crossref]